Highlights Baxter International Inc. Berne S.E.

Equities

BAX

US0718131099

Delayed Berne S.E. Other stock markets 12:00:00 2023-04-06 EDT			5-day change	1st Jan Change
38.11 ^CHF	+3.50%		-.--%	-.--%

06-20	Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors	CI
06-12	Transcript : Baxter International Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ex-dividend day	05-30	FA
Baxter International Inc. Announces New Data Showing Expanded Hemodialysis, Known as HDX Therapy	05-29	CI
Baxter International Inc. Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication	05-13	CI
Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31	05-07	MT
Baxter International Inc. Declares Quarterly Dividend, Payable on July 1, 2024	05-07	CI
Baxter International Q1 Adjusted Earnings, Net Sales Gain; Boosts 2024 Adjusted Profit Guidance	05-02	MT
(BAX) BAXTER INTERNATIONAL Forecasts Q2 Adjusted EPS Range $0.65 - $0.67	05-02	MT
(BAX) BAXTER INTERNATIONAL Sees Fiscal Year 2024 Adjusted EPS Range $2.88 - $2.98	05-02	MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Adjusted EPS $0.65 vs. $0.61 Estimate	05-02	MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B	05-02	MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B	05-02	MT
Tranche Update on Baxter International Inc.'s Equity Buyback Plan announced on July 25, 2012.	05-02	CI
Baxter International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Baxter International Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024	05-02	CI
Edwards Lifesciences Corporation: The story continues	04-23
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S	04-11	CI
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period	04-04	MT
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump	04-01	MT
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy	04-01	CI
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data	03-05	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Baxter International Inc. Berne S.E.

Equities

BAX

US0718131099

Highlights

Filters